Lineage Cell Therapeutics appoints Board member Michael Mulroy as the Chairman of its Board of Directors
– USA, CA – Lineage Cell Therapeutics, Inc. (NYSE American / TASE: LCTX) today announced the appointment of Michael Mulroy as the Chairman of the Board of Directors effective as of April 27, 2024, replacing Al Kingsley who passed away.…